Optimistic Outlook for Relmada Therapeutics: A Comprehensive Analysis and Buy Rating

TipRanksMar 21 14:17

Earnings Call Summary | Relmada Therapeutics(RLMD.US) Q4 2023 Earnings Conference

The following is a summary of the Relmada Therapeutics, Inc. (RLMD) Q4 2023 Earnings Call Transcript:Financial Performance:Information not provided.Business Progress:Information not provided.More deta

Futu NewsMar 21 11:30 · Conference Call

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 20 22:27

Relmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial Results

Yahoo FinanceMar 20 05:31

Relmada Therapeutics Q4 EPS $(0.84) Misses $(0.83) Estimate

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.83) by 1.2 percent. This is a 34.38 percent increase over losses of

BenzingaMar 20 04:33

Recap: Relmada Therapeutics Q4 Earnings

Relmada Therapeutics (NASDAQ:RLMD) reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:15 PM.Here's what investors need to know about the announcement.EarningsRelmada Therapeutics missed

BenzingaMar 20 04:30